|
KIF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.70269999999673E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.384400E-04 |
| Normal-vs-Stage2 |
2.577400E-03 |
| Normal-vs-Stage3 |
7.80660000000433E-05 |
| Normal-vs-Stage4 |
1.98906999999693E-05 |
| Stage1-vs-Stage2 |
5.371600E-01 |
| Stage1-vs-Stage3 |
1.803180E-01 |
| Stage1-vs-Stage4 |
1.734410E-02 |
| Stage2-vs-Stage3 |
6.168800E-01 |
| Stage2-vs-Stage4 |
2.372800E-01 |
| Stage3-vs-Stage4 |
3.781800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48169999998993E-05 |
| Normal-vs-AfricanAmerican |
2.631700E-04 |
| Normal-vs-Asian |
2.961800E-04 |
| Caucasian-vs-AfricanAmerican |
8.312200E-01 |
| Caucasian-vs-Asian |
1.840590E-01 |
| AfricanAmerican-vs-Asian |
2.193400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.56339999999056E-06 |
| Normal-vs-Female |
9.867700E-02 |
| Male-vs-Female |
2.315500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.982110E-03 |
| Normal-vs-Extreme_Weight |
2.68729999997053E-06 |
| Normal-vs-Obese |
2.615600E-03 |
| Normal-vs-Extreme_Obese |
4.225700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.334800E-01 |
| Normal_Weight-vs-Obese |
5.799400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.106600E-01 |
| Extreme_Weight-vs-Obese |
1.926590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.440400E-01 |
| Obese-vs-Extreme_Obese |
9.148600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.081900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.344000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.25959999996983E-06 |
| Normal-vs-Age(81-100Yrs) |
2.371400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.644400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.819400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.959000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.757900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.043000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.772200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.358000E-04 |
| Normal-VS-Type2 PRCC |
9.85839999999572E-05 |
| Normal-VS-KIRP CIMP |
3.837300E-03 |
| Normal-VS-Unclassified PRCC |
9.823800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.929200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.154000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.786200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.896600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.346420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.558200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.05980000021067E-07 |
| Normal-vs-N1 |
3.5439000000026E-05 |
| Normal-vs-N2 |
3.909600E-02 |
| N0-vs-N1 |
5.830200E-01 |
| N0-vs-N2 |
8.487200E-01 |
| N1-vs-N2 |
7.022000E-01 |
|
|
